News of the WeekClinical Trials

Agency Wants to Stop Shopping for Best Deal

+ See all authors and affiliations

Science  14 Jun 2002:
Vol. 296, Issue 5575, pp. 1953
DOI: 10.1126/science.296.5575.1953

You are currently viewing the summary.

View Full Text

Summary

The U.S. Food and Drug Administration is worried that clinical researchers might ask safety officials to approve studies involving human subjects that have been rejected by other panels. To deter "IRB shopping," the government has proposed that researchers be required to tell safety panels about any prior reviews. But last week the biomedical community gave the plan a mixed reception.

    Related Content